- Home
- VTYX vs STSS Comparison
VTYX vs STSS Comparison
Compare VTYX & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- STSS
- Stock Information
- Founded
- VTYX 2018
- STSS 2017
- Country
- VTYX United States
- STSS United States
- Employees
- VTYX N/A
- STSS N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- STSS Medical/Dental Instruments
- Sector
- VTYX Health Care
- STSS Health Care
- Exchange
- VTYX Nasdaq
- STSS Nasdaq
- Market Cap
- VTYX 154.9M
- STSS 124.5M
- IPO Year
- VTYX 2021
- STSS 2022
- Fundamental
- Price
- VTYX $8.09
- STSS $3.92
- Analyst Decision
- VTYX Buy
- STSS
- Analyst Count
- VTYX 3
- STSS 0
- Target Price
- VTYX $12.50
- STSS N/A
- AVG Volume (30 Days)
- VTYX 9.8M
- STSS 269.4K
- Earning Date
- VTYX 11-06-2025
- STSS 11-13-2025
- Dividend Yield
- VTYX N/A
- STSS N/A
- EPS Growth
- VTYX N/A
- STSS N/A
- EPS
- VTYX N/A
- STSS N/A
- Revenue
- VTYX N/A
- STSS $222,722.00
- Revenue This Year
- VTYX N/A
- STSS N/A
- Revenue Next Year
- VTYX N/A
- STSS N/A
- P/E Ratio
- VTYX N/A
- STSS N/A
- Revenue Growth
- VTYX N/A
- STSS N/A
- 52 Week Low
- VTYX $0.78
- STSS $3.36
- 52 Week High
- VTYX $9.50
- STSS $1,248.27
- Technical
- Relative Strength Index (RSI)
- VTYX 76.14
- STSS 29.28
- Support Level
- VTYX $5.75
- STSS $4.60
- Resistance Level
- VTYX $9.50
- STSS $5.49
- Average True Range (ATR)
- VTYX 0.78
- STSS 0.44
- MACD
- VTYX 0.33
- STSS -0.03
- Stochastic Oscillator
- VTYX 76.85
- STSS 2.58
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.